CHI基金(CHI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CHI CHI基金

交易中 12-23 12:28:23 EST

11.97

-0.03

-0.29%

最高12.13	最低11.93	成交量6.32万
今开11.99	昨收12.00	日振幅1.66%
总市值8.85亿	流通市值0.00	总股本7,396万
成交额75.94万	换手率--	流通股本0.00
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CHI","market":"US","secType":"STK","nameCN":"CHI基金","latestPrice":11.965,"timestamp":1734974869420,"preClose":12,"halted":0,"volume":63217,"delay":0,"floatShares":0,"shares":73964587,"eps":0.930142,"marketStatus":"交易中","marketStatusCode":2,"change":-0.035,"latestTime":"12-23 12:28:23 EST","open":11.99,"high":12.1292,"low":11.93,"amount":759402.43071,"amplitude":0.0166,"askPrice":11.98,"askSize":100,"bidPrice":11.96,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.930142,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"adjPreClose":12,"adrRate":0,"dividendRate":0.095278,"preHourTrading":{"tag":"盘前","latestPrice":12,"preClose":12,"latestTime":"08:02 EST","volume":4,"amount":48.7,"timestamp":1734958976499},"postHourTrading":{"tag":"盘后","latestPrice":12,"preClose":12,"latestTime":"16:00 EST","volume":2,"amount":24,"timestamp":1734728403507},"volumeRatio":0.75568},"requestUrl":"/m/hq/s/CHI/wiki","defaultTab":"wiki","newsList":[{"id":"2492425029","title":"BRILLIANCE CHI修订股息政策 目标分派不少于50%溢利","url":"https://stock-news.laohu8.com/highlight/detail?id=2492425029","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492425029?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:51","pubTimestamp":1734486702,"startTime":"0","endTime":"0","summary":"财中社12月18日电BRILLIANCECHI（01114）发布公告，董事会于2024年12月17日批准并采纳了经修订的股息政策。根据新的政策，董事会在决定是否建议派发股息及确定股息金额时，将考虑华晨宝马汽车有限公司在相关财年已派付的现金股息，以及本集团的整体经营业绩、财务表现、营运资金需求、资本开支需求、财务状况和可供分派的储备等多个因素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412183271778848.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CHI"],"gpt_icon":0},{"id":"2492109699","title":"BRILLIANCE CHI公布采纳经修订股息政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2492109699","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492109699?lang=zh_cn&edition=full","pubTime":"2024-12-18 08:03","pubTimestamp":1734480180,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　BRILLIANCE CHI（01114）发布公告，于2019年3月26日，公司董事会采纳一项股息政策。于2024年12月17日，董事会批准及采纳经修订股息政策。根据经修订股息政策，在决定是否建议派发╱宣派股息及在厘定股息金额时，视乎华晨宝马汽车有限公司于相关财政年度已派付的现金股息。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-18/doc-inczvssz5102590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CHI"],"gpt_icon":0},{"id":"2492963260","title":"BRILLIANCE CHI(01114)：采纳经修订股息政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2492963260","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492963260?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:37","pubTimestamp":1734446271,"startTime":"0","endTime":"0","summary":"智通财经APP讯，BRILLIANCE CHI(01114)发布公告，于2019年3月26日，公司董事会采纳一项股息政策。于2024年12月17日，董事会批准及采纳经修订股息政策。根据经修订股息政策，在决定是否建议派发╱宣派股息及在厘定股息金额时，视乎华晨宝马汽车有限公司于相关财政年度已派付的现金股息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572939691.SGD","LU0572940350.SGD","BK1539","LU0229945570.USD","CHI","01114","LU0543330566.HKD","BK1119","LU0264606111.USD"],"gpt_icon":0},{"id":"2490800988","title":"更新 4-龙沙退出保健品和配料业务，专注于合同开发，寻求交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2490800988","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490800988?lang=zh_cn&edition=full","pubTime":"2024-12-12 20:47","pubTimestamp":1734007675,"startTime":"0","endTime":"0","summary":"分析师说，计划中的 CHI 退出应能消除龙沙增长的阻力，并加强其资产负债表，尽管这将导致非现金减记。该公司告诉投资者，它将在2025年确定与CHI有关的下一步措施，因为它将专注于为制药公司生产药品的合同开发和制造组织 业务。龙沙财务总监迪克告诉记者，龙沙还将更加注重并购，寻找 \"技术或能力方面的绝佳机会\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","LU2237443549.SGD","LU0238689110.USD","LU1093756325.SGD","LLY","LU1057294990.SGD","LU2491049909.HKD","LU0289739699.SGD","IE0004445239.USD","LU1868837300.USD","IE0009355771.USD","LU1917777945.USD","LU1868836757.USD","LU0354030511.USD","LU0256863811.USD","LU0096364046.USD","LU1267930730.SGD","LU2468319806.SGD","SG9999015952.SGD","LU0820561818.USD","LU2265009873.SGD","BK4599","LU0466842654.USD","SGXZ31699556.SGD","CHI","IE00BJT1NW94.SGD","LU0471298694.HKD","SGXZ81514606.USD","LU0061475181.USD","SG9999018857.SGD","LU2237438978.USD","LU1623119135.USD","LU1868836591.USD","LU2237443622.USD","LU1988902786.USD","LU1291159041.SGD","BK4581","LU2237443978.SGD","BK4585","LU2361045086.USD","LU2361044949.HKD","BK4534","LU1093756168.USD","IE00B1BXHZ80.USD","LU1804176565.USD","LU1551013425.SGD","LU2237443382.USD","LU0006306889.USD","LU1064131342.USD","LU0882574055.USD"],"gpt_icon":1},{"id":"2488679736","title":"CHI HO DEV(08423)：何颖珊获委任为独立非执行董事及提名委员会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=2488679736","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488679736?lang=zh_cn&edition=full","pubTime":"2024-12-02 21:37","pubTimestamp":1733146635,"startTime":"0","endTime":"0","summary":"智通财经APP讯，CHI HO DEV(08423)发布公告，何颖珊女士已获委任为独立非执行董事及公司提名委员会成员，自2024年12月2日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08423","CHI","BK1148"],"gpt_icon":0},{"id":"2486390578","title":"CHI HO DEV(08423)发布中期业绩，净利润901万港元，同比增长47.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486390578","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486390578?lang=zh_cn&edition=full","pubTime":"2024-11-28 19:57","pubTimestamp":1732795039,"startTime":"0","endTime":"0","summary":"CHI HO \nDEV(08423)发布截至2024年9月30日止六个月业绩，收益...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_39.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_39.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["CHI","08423"],"gpt_icon":0},{"id":"2485723069","title":"CHI HO DEV(08423)发盈喜 预计中期纯利同比增加至800万-1000万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485723069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485723069?lang=zh_cn&edition=full","pubTime":"2024-11-22 18:31","pubTimestamp":1732271473,"startTime":"0","endTime":"0","summary":"智通财经APP讯，CHI HO DEV(08423)发布公告，集团预期于截至2024年9月30日止六个月将取得综合纯利800万港元至1000万港元，而上年同期则为综合纯利约610万港元。综合纯利的预期增加主要由于混合项目及新建基本工程的收益增加，导致总收益及毛利均有所增加。该影响部分被预期信用损失模型下减值损失净额增加所部分抵销。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHI","08423","BK1148"],"gpt_icon":0},{"id":"2480930302","title":"BRILLIANCE CHI(01114)：张悦获委任为董事会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2480930302","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480930302?lang=zh_cn&edition=full","pubTime":"2024-11-04 20:34","pubTimestamp":1730723670,"startTime":"0","endTime":"0","summary":"智通财经APP讯，BRILLIANCE CHI(01114)发布公告，公司执行董事及行政总裁张悦已获委任为董事会主席;及根据香港联合交易所有限公司证券上市规则第3.05条规定公司授权代表，两者均由2024年11月4日起生效;及执行董事张巍已获委任为董事会辖下子公司高管任命委员会成员，由2024年11月4日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572940350.SGD","BK1539","LU0572939691.SGD","LU0264606111.USD","LU0229945570.USD","01114","BK1119","LU0543330566.HKD","CHI"],"gpt_icon":0},{"id":"2479253274","title":"北美RISC-V峰会，四大亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=2479253274","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479253274?lang=zh_cn&edition=full","pubTime":"2024-10-30 18:22","pubTimestamp":1730283736,"startTime":"0","endTime":"0","summary":"到2024年，使用RISC-V内核的SoC数量将达到20亿。近日，在加州圣克拉拉举行的RISC-V 峰会上，包括 Andes Technology、RISC-V International、Arteris 和 Codasip 在内的四家公司发布了重要声明。为期两天的峰会为快速发展的 RISC-V 技术社区提供了一个教育、信息和讨论的论坛。AndesCore D45-SE 是一款 32 位、八级和双发射 RISC-V 处理器。RISC-V 国际组织宣布批准64 位 RISC-V 实施配置文件标准RVA23。在此最新举措中，Codasip 已将其 CHERI SDK 捐赠给 CHERI 联盟，以确保 RISC-V 开发者社区能够获得更大的可用性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/243380","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["AIP","BK4588","LU1720051017.SGD","LU1548497426.USD","LU2360107325.USD","LU1861219969.SGD","IE00BZ199S13.USD","BK4097","BK4585","LU1861220033.SGD","LU2298322129.HKD","LU2357305700.SGD","AMBA","LU0724618433.USD","BK4512","LU1861214812.USD","IE00BD6J9T35.USD","LU0348723411.USD","CHI","LU1854103824.USD","LU0124384867.USD","LU1854104046.USD","LU1978683503.SGD","ON","LU1861215975.USD","BK4141","LU1720051108.HKD"],"gpt_icon":0},{"id":"2474235588","title":"更新版 1-美国 FDA 拒绝批准西兰治疗婴儿低血糖的药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2474235588","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474235588?lang=zh_cn&edition=full","pubTime":"2024-10-09 07:37","pubTimestamp":1728430627,"startTime":"0","endTime":"0","summary":"     路透10月8日 - 丹麦生物技术公司周二表示，美国卫生监管机构拒绝批准新西兰制药公司用于预防和治疗遗传性疾病患儿低血糖的  药物，这是该药第二次被拒。该公司说，美国食品和药物管理局 在其所谓的 \"完整答复函 \"中提到了第三方生产设施重新检查的时间。不过，信中并未提及对药物达西胰高血糖素的临床数据包或安全性的任何担忧。此前，FDA 曾以第三方生产设施存在缺陷为由拒绝了 。FDA 没有立即回复路透的置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHI"],"gpt_icon":0},{"id":"2474238908","title":"丹麦的西兰公司向美国 FDA 提供治疗婴儿低血糖药物的最新信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2474238908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474238908?lang=zh_cn&edition=full","pubTime":"2024-10-09 07:02","pubTimestamp":1728428572,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透10月8日 - 丹麦的西兰制药公司  周二称，美国食品和药物管理局(FDA)，已就其预防和治疗遗传性疾病患儿低血糖的药物发出了完全回复函(CRL)。 西兰正在寻求FDA批准达西胰高血糖素，该药计划用于7天或7天以上的先天性高胰岛素血症患者(CHI)，这是一种遗传性疾病，患者的胰腺会分泌过多的胰岛素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU0390134368.USD","BK4530","BK4585","CRL","BK4588","CHI"],"gpt_icon":0},{"id":"2473122468","title":"BRILLIANCE CHI(01114)委任林绮华为法律程序文件代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2473122468","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473122468?lang=zh_cn&edition=full","pubTime":"2024-10-07 17:09","pubTimestamp":1728292163,"startTime":"0","endTime":"0","summary":"智通财经APP讯，BRILLIANCE CHI(01114)发布公告，由2024年10月7日起，公司的公司秘书林绮华女士已获委任为根据香港法例第622章公司条例第16部代表公司在中国香港接受法律程序文件及通知的送达的公司获授权代表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1190567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572939691.SGD","LU0572940350.SGD","BK1119","01114","LU0229945570.USD","CHI","LU0543330566.HKD","BK1539","LU0264606111.USD"],"gpt_icon":0},{"id":"2470033811","title":"美国OTC市场Eiger Biopharmaceuticals, Inc.盘中异动 早盘快速下跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470033811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470033811?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:18","pubTimestamp":1727450323,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时18分，美国OTC市场Eiger Biopharmaceuticals, Inc.股票出现异动，股价急速下跌5.88%。美国OTC市场Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。美国OTC市场Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231843ab66870c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231843ab66870c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","HDV","PBH","EIGRQ","PL","BK4123","CHI","BK4585","BK4007"],"gpt_icon":0},{"id":"2468508030","title":"美国OTC市场Eiger Biopharmaceuticals, Inc.（EIGRQ.us）盘中异动 急速下跌64.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468508030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468508030?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:16","pubTimestamp":1726755361,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时16分，美国OTC市场Eiger Biopharmaceuticals, Inc.股票出现波动，股价急速下挫64.71%。美国OTC市场Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。美国OTC市场Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192216019f0803d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192216019f0803d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4123","HDV","PBH","PL","EIGRQ","BK4585","BK4588","CHI"],"gpt_icon":0},{"id":"2466765400","title":"BRILLIANCE CHI(01114)：吴小安辞任董事会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2466765400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466765400?lang=zh_cn&edition=full","pubTime":"2024-09-11 19:50","pubTimestamp":1726055427,"startTime":"0","endTime":"0","summary":"智通财经APP讯，BRILLIANCE CHI(01114)发布公告，吴小安因其他事务已提呈辞任公司执行董事;董事会主席;董事会辖下提名委员会、薪酬委员会及子公司高管任命委员会成员;根据香港联合交易所有限公司证券上市规则第3.05条规定的公司授权代表;根据香港法例第622章公司条例第16部代表公司在香港接受法律程序文件及通知的送达的公司获授权代表(法律程序文件代理人);及公司子公司及联营公司的所有其他职位，全部由2024年9月11日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1182141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572939691.SGD","LU0264606111.USD","CHI","BK1119","01114","LU0543330566.HKD","BK1539","LU0572940350.SGD","LU0229945570.USD"],"gpt_icon":0},{"id":"2461736395","title":"BRILLIANCE CHI(01114)发布中期业绩 股东应占溢利14.73亿元 同比减少60.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461736395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461736395?lang=zh_cn&edition=full","pubTime":"2024-08-22 17:49","pubTimestamp":1724320187,"startTime":"0","endTime":"0","summary":"智通财经APP讯，BRILLIANCE CHI(01114)发布截至2024年6月30日止六个月的未经审核中期业绩，该集团期内取得收益5.18亿元(人民币，下同)，同比增加2.01%;股东应占溢利14.73亿元，同比减少60.65%;每股基本盈利0.29201元。公告称，收益增加主要源于来自电动及混合动力车制造商的订单稳步上升，但增长因市场竞争加剧令汽车金融收益减少而被抵销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1168531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572940350.SGD","BK1539","LU0572939691.SGD","CHI","BK1119","01114","LU0264606111.USD","LU0229945570.USD","LU0543330566.HKD"],"gpt_icon":0},{"id":"2459977297","title":"BRILLIANCE CHI(01114)发盈警 预计中期除所得税开支后溢利减少约60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459977297","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459977297?lang=zh_cn&edition=full","pubTime":"2024-08-13 20:15","pubTimestamp":1723551354,"startTime":"0","endTime":"0","summary":"智通财经APP讯，BRILLIANCE CHI(01114)发布公告，集团预期截至2024年6月30日止六个月的未经审核除所得税开支后溢利将较2023年同期减少约60%。报告期的预期溢利减少主要由于集团的主要联营公司华晨宝马汽车有限公司的业绩下滑;及期内附属公司已付股息预扣税约人民币14.74亿元所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0264606111.USD","LU0572939691.SGD","LU0229945570.USD","CHI","LU0572940350.SGD","01114","LU0543330566.HKD","BK1119","BK1539"],"gpt_icon":0},{"id":"2452513025","title":"BRILLIANCE CHI(01114)：大东政府与华晨雷诺已就建议征收事项签订征收补偿协议书","url":"https://stock-news.laohu8.com/highlight/detail?id=2452513025","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452513025?lang=zh_cn&edition=full","pubTime":"2024-07-17 19:26","pubTimestamp":1721215584,"startTime":"0","endTime":"0","summary":"智通财经APP讯，BRILLIANCE CHI(01114)公布，有关大东政府征收华晨雷诺经营的工厂所在的土地，华晨雷诺告知，于2024年 7月 16日，大东政府与华晨雷诺已就建议征收事项签订征收补偿协议书，据此，大东政府已同意货币补偿总金额约人民币4.51亿元。华晨雷诺告知，于 2024年7月 16日，业主与华晨雷诺已就该等物业的租赁订立租赁协议，租赁期限自向华晨雷诺交付该等物业之日起10年(交付应自租赁协议之日起30个营业日内落实)。该等物业将由华晨雷诺用作其生产经营 的新办公物业及工厂。该等物业为中华人民共和国辽宁省沈阳市大东区东望街39号A工厂房产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152242.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572939691.SGD","LU0572940350.SGD","BK1539","LU0229945570.USD","CHI","01114","LU0543330566.HKD","BK1119","LU0264606111.USD"],"gpt_icon":0},{"id":"2452130266","title":"【BRILLIANCE CHI(01114.HK)：大东政府与华晨雷诺已就建议征收事项签订征收补偿协议书 】智通财经APP讯，BRILLIANCE CHI(01114.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452130266","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452130266?lang=zh_cn&edition=full","pubTime":"2024-07-17 19:26","pubTimestamp":1721215584,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CHI","LU0543330566.HKD","LU0264606111.USD","LU0229945570.USD","01114","LU0572940350.SGD","BK1119","LU0572939691.SGD","BK1539"],"gpt_icon":0},{"id":"2446102353","title":"CHI HO DEV(08423)股价下跌5.085%，现价港币$0.056","url":"https://stock-news.laohu8.com/highlight/detail?id=2446102353","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446102353?lang=zh_cn&edition=full","pubTime":"2024-06-26 15:50","pubTimestamp":1719388200,"startTime":"0","endTime":"0","summary":"[下跌股]CHI HO DEV(08423) 股价在下午03:50比前收市价下跌5.085%，现股价为港币$0.056。至目前为止，今日最高价为$0.059，而最低价为$0.056。总成交量为17万股，总成交金额为港币$1万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240626866/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1148","08423","CHI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calamos.com","stockEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0058},{"period":"3month","weight":0.0248},{"period":"6month","weight":0.023},{"period":"1year","weight":0.1594},{"period":"ytd","weight":0.1583}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CALAMOS CONVERTIBLE OPPORTUNITIES AND INCOME FUND是一家多元化、封闭式管理的投资公司，于2002年6月开始投资运营。该基金于2002年4月17日根据特拉华州法律成立为法定信托，并根据1940年法案进行了注册。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.026428},{"month":2,"riseRate":0.5,"avgChangeRate":-0.004837},{"month":3,"riseRate":0.5,"avgChangeRate":-0.01503},{"month":4,"riseRate":0.666667,"avgChangeRate":0.01456},{"month":5,"riseRate":0.5,"avgChangeRate":-0.000715},{"month":6,"riseRate":0.75,"avgChangeRate":0.013968},{"month":7,"riseRate":0.75,"avgChangeRate":0.025361},{"month":8,"riseRate":0.538462,"avgChangeRate":-0.010797},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.029492},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.001383},{"month":11,"riseRate":0.538462,"avgChangeRate":0.015587},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.013376}],"exchange":"NASDAQ","name":"CHI基金","nameEN":"Calamos Convertible Opportunities and Income Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CHI基金(CHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CHI基金(CHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CHI基金,CHI,CHI基金股票,CHI基金股票老虎,CHI基金股票老虎国际,CHI基金行情,CHI基金股票行情,CHI基金股价,CHI基金股市,CHI基金股票价格,CHI基金股票交易,CHI基金股票购买,CHI基金股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CHI基金(CHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CHI基金(CHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}